Goldman Sachs Raises PT on CME Group to $270

by Juan Lopez, Benzinga Staff Writer
February 3, 2012 7:46 AM | 8 seconds read | Make a Comment
Loading...
Loading...
Goldman Sachs has raised the price target on CME Group
CME
from $250 to $270 and maintains its Neutral rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Click to see more Analyst Ratings updates
Posted In: Price TargetPre-Market OutlookAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!